Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ovarian Neoplasms

  Free Subscription

Articles published in Histopathology

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    July 2020
  1. BUSCA A, Nofech-Mozes S, Olkhov-Mitsel E, Gien LT, et al
    Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systems.
    Histopathology. 2020;77:26-34.
    PubMed     Abstract available

    January 2020
    Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions.
    Histopathology. 2020;76:76-92.
    PubMed     Abstract available

  3. VERMIJ L, Smit V, Nout R, Bosse T, et al
    Incorporation of molecular characteristics into endometrial cancer management.
    Histopathology. 2020;76:52-63.
    PubMed     Abstract available

  4. WILLIAMS AT, Ganesan R
    Role of the pathologist in assessing response to treatment of ovarian and endometrial cancers.
    Histopathology. 2020;76:93-101.
    PubMed     Abstract available

  5. BERNEY DM, Stoneham S, Arora R, Shamash J, et al
    Ovarian germ cell tumour classification: views from the testis.
    Histopathology. 2020;76:25-36.
    PubMed     Abstract available

  6. EUSCHER ED, Malpica A
    Gynaecological malignancies and sentinel lymph node mapping: an update.
    Histopathology. 2020;76:139-150.
    PubMed     Abstract available

  7. RABBAN JT, Karnezis AN, Devine WP
    Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
    Histopathology. 2020;76:11-24.
    PubMed     Abstract available

  8. CASEY L, Singh N
    Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances.
    Histopathology. 2020;76:37-51.
    PubMed     Abstract available

    July 2019
  9. PETERS EEM, Bartosch C, McCluggage WG, Genestie C, et al
    Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.
    Histopathology. 2019;75:128-136.
    PubMed     Abstract available

    February 2019
  10. WANG L, Rambau PF, Kelemen LE, Anglesio MS, et al
    Nuclear beta-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome.
    Histopathology. 2019;74:452-462.
    PubMed     Abstract available

  11. MCCLUGGAGE WG, Chong AS, Attygalle AD, Clarke BA, et al
    Expanding the morphological spectrum of ovarian microcystic stromal tumour.
    Histopathology. 2019;74:443-451.
    PubMed     Abstract available

    December 2018
  12. DARB-ESFAHANI S, Kolaschinski I, Trillsch F, Mahner S, et al
    Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
    Histopathology. 2018;73:1002-1012.
    PubMed     Abstract available

    November 2018
  13. KOOPMAN T, van der Vegt B, Dijkstra M, Bart J, et al
    HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.
    Histopathology. 2018;73:852-863.
    PubMed     Abstract available

    September 2018
  14. TURASHVILI G, Grisham RN, Chiang S, DeLair DF, et al
    BRAF(V)(600E) mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary.
    Histopathology. 2018;73:438-443.
    PubMed     Abstract available

    July 2018
  15. MOORE M, Boyde A, Rowlands GL, McCluggage WG, et al
    Primary fallopian tube sex cord tumour: tubal counterpart of uterine tumour resembling ovarian sex cord tumour.
    Histopathology. 2018;73:175-178.

    March 2018
  16. NOGALES FF, Prat J, Schuldt M, Cruz-Viruel N, et al
    Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
    Histopathology. 2018;72:634-647.
    PubMed     Abstract available

  17. SINGH P, Kaushal V, Rai B, Rajwanshi A, et al
    The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma.
    Histopathology. 2018;72:619-625.
    PubMed     Abstract available

  18. ROTH LM, Cheng L
    Classical gonadoblastoma: its relationship to the 'dissecting' variant and undifferentiated gonadal tissue.
    Histopathology. 2018;72:545-555.
    PubMed     Abstract available

    January 2018
  19. VAN GOOL IC, Ubachs JEH, Stelloo E, de Kroon CD, et al
    Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.
    Histopathology. 2018;72:248-258.
    PubMed     Abstract available

  20. YU G, Qu G
    High molecular weight caldesmon expression in ovarian adult granulosa cell tumour and fibrothecoma.
    Histopathology. 2018;72:359-361.

    June 2017
  21. MCCLUGGAGE WG, Witkowski L, Clarke BA, Foulkes WD, et al
    Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm.
    Histopathology. 2017;70:1147-1154.
    PubMed     Abstract available

    February 2017
  22. MCINTYRE JB, Rambau PF, Chan A, Yap S, et al
    Molecular alterations in indolent, aggressive and recurrent ovarian low-grade serous carcinoma.
    Histopathology. 2017;70:347-358.
    PubMed     Abstract available

    January 2017
  23. STEWART CJ, Bowtell DD, Doherty DA, Leung YC, et al
    Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma.
    Histopathology. 2017;70:309-313.
    PubMed     Abstract available

    October 2016
  24. HOANG LN, Lee YS, Karnezis AN, Tessier-Cloutier B, et al
    Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
    Histopathology. 2016;69:560-9.
    PubMed     Abstract available

    September 2016
  25. SNIR OL, Buza N, Hui P
    Mucinous epithelial tumours arising from ovarian mature teratomas: a tissue genotyping study.
    Histopathology. 2016;69:383-92.
    PubMed     Abstract available

    May 2016
  26. BAKHSH S, Kinloch M, Hoang LN, Soslow RA, et al
    Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.
    Histopathology. 2016;68:916-24.
    PubMed     Abstract available

  27. HIROSE T, Nobusawa S, Kusanishi H
    Ovarian primitive-type neuroectodermal tumour composed of desmoplastic/nodular medulloblastoma-like and atypical teratoid/rhabdoid tumour components.
    Histopathology. 2016;68:939-42.

    March 2016
  28. TAYLOR J, Clarke BA, Hasan NU, Gasljevic G, et al
    Ovarian hilar proliferations resembling Sertoli cell tumours: microscopic neoplasms or non-neoplastic remnants?
    Histopathology. 2016;68:596-602.
    PubMed     Abstract available

  29. KATO N, Kurotaki H, Uchigasaki S, Fukase M, et al
    Ovarian clear cell carcinoma with plasma cell-rich inflammatory stroma: a clear cell carcinoma subgroup with distinct clinicopathological features.
    Histopathology. 2016;68:588-95.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.